Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Auto rebalancing and capital gains management covers how automated tweaks can curb tax impact while preserving strategy.
28,655 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Tech insiders are stepping up their open-market purchases in software, chipmakers, and AI platforms, reviving a contr...
Strategy unveils a private repurchase of roughly $1.5 billion in convertible notes, funded by cash, ATM proceeds, and...
A $300,000 investment in a quality dividend ETF could generate roughly $9,000–$11,000 a year in ordinary cash flow, p...
Investors are buzzing about a hypothetical $165 billion payout for Elon Musk tied to SpaceX milestones. Traders say t...
As AI reshapes software profits, select lightly priced players with durable moats and capable leadership attract barg...
Adobe shares have a tough year, yet JPMorgan sees upside. A $420 year-end target hinges on improving ARR, rising RPO,...
Qualcomm exploded higher, gaining about 70% in a single month as it pivots toward AI data-center demand. Investors ar...
FuelCell Energy leads a hydrogen stock rebound with a 15% jump as investors chase AI data center exposure. Bloom Ener...
BITO’s 0.95% fee is only part of the cost. When roll losses from contango are added, total annual drag nears 3% for b...
The S&P 500 is posting its fastest earnings growth in nearly five years, led by under-the-radar firms across multiple...
A high-profile crypto photo shoot has reignited debates about credibility, PR tactics, and the road ahead for a marke...